ASCO GI 2023 | Practical considerations regarding genomic testing for molecular aberrations

Michele Ghidini, MD, PhD, Policlinico di Milano, Milan, Italy, provides an overview of practical considerations regarding genomic testing for molecular aberrations in patients with colorectal cancer (CRC). This interview took place at the American Society of Clinical Oncology (ASCO) 2023 Gastrointestinal Cancers (GI) Symposium in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

View our new feature exploring genomic biomarkers in metastatic colorectal cancer here: https://bit.ly/3DcSevZ